SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Vital Farms, Inc. (VITL) trades at a trailing P/E of 8.5, forward P/E of 11.7. Trailing earnings yield is 11.72%, forward earnings yield 8.58%. PEG 0.39 (Peter Lynch undervalued ≤1.0). Graham Number is $16.23.
Criteria proven by this page:
- VALUE (97/100, Pass) — P/E is below market average (8.5); PEG ≤ 1.0 — Peter Lynch undervalued (0.39); analyst target implies upside (+275.1%); earnings yield beats bond yields (11.72%).
- PEG Ratio 0.39 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 11.72% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $47.83 (+275.1% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 82/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
97/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — VITL
Valuation Multiples
P/E (TTM)8.5
Forward P/E11.7
PEG Ratio0.39
Forward PEG0.50
P/B Ratio1.61
P/S Ratio0.75
EV/EBITDA5.1
Per Share Data
EPS (TTM)$1.49
Forward EPS (Est.)$1.09
Book Value / Share$7.88
Revenue / Share$17.03
FCF / Share$-1.08
Yields & Fair Value
Earnings Yield11.72%
Forward Earnings Yield8.58%
Dividend Yield0.00%
Graham Number$16.23
SharesGrow IV$14.44 (+13.3%)
Analyst Target$47.83 (+275.1%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2017 |
-626.1 |
0.00 |
0.00 |
16.24 |
- |
| 2018 |
207.6 |
-0.52 |
235.31 |
11.28 |
- |
| 2019 |
504.7 |
-8.57 |
140.62 |
8.55 |
- |
| 2020 |
82.5 |
0.24 |
5.11 |
3.39 |
- |
| 2021 |
297.6 |
-3.70 |
4.77 |
2.77 |
- |
| 2022 |
484.8 |
-9.84 |
3.83 |
1.68 |
- |
| 2023 |
25.3 |
0.01 |
3.35 |
1.37 |
- |
| 2024 |
29.8 |
0.29 |
5.91 |
2.63 |
- |
| 2025 |
21.9 |
1.14 |
4.13 |
1.91 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2017 |
$-0.06 |
$74M |
$-1.92M |
-2.6% |
| 2018 |
$0.16 |
$106.71M |
$5.8M |
5.4% |
| 2019 |
$0.06 |
$140.73M |
$2.39M |
1.7% |
| 2020 |
$0.27 |
$214.28M |
$8.8M |
4.1% |
| 2021 |
$0.06 |
$260.9M |
$2.43M |
0.9% |
| 2022 |
$0.03 |
$362.05M |
$1.25M |
0.3% |
| 2023 |
$0.59 |
$471.86M |
$25.57M |
5.4% |
| 2024 |
$1.18 |
$606.31M |
$53.39M |
8.8% |
| 2025 |
$1.44 |
$759.44M |
$66.28M |
8.7% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$1.20 |
$1.09 – $1.32 |
$901.85M |
$890.78M – $911.46M |
7 |
| 2027 |
$1.45 |
$1.31 – $1.70 |
$1.07B |
$1.04B – $1.11B |
7 |
| 2028 |
$1.66 |
$1.07 – $2.24 |
$1.24B |
$1.24B – $1.24B |
2 |
